MINNEAPOLIS, July 16 In a statement released today, BudHayden, a director serving as interim CEO of Bioenergy, Inc., a privately heldMinneapolis-based integrative life science company, announced Raj Khankari,PhD, will join the company as its new CEO on August 1, 2008.
Dr. Khankari joins the company from CIMA Labs Inc., a Cephalon company,where he served as General Manager, CIMA Labs Inc., and Vice President forWorldwide Drug Delivery Technologies. Dr. Khankari earned his initial degreesin Pharmaceutics from universities in India. Dr. Khankari also has a PhD inPharmaceutics and an MBA from the University of Minnesota.
In addition to holding several patents, Dr. Khankari has been widelypublished in several peer reviewed journals and has been a presenter at morethan two dozen national and international meetings.
In making the announcement, Mr. Hayden stated, "We are very pleased tohave Dr. Khankari head up our Company. His scientific background, includinghis successful track record in working with the Food and Drug Administration(FDA) on new product discoveries, in conjunction with the experience he gainedin holding senior management positions, will provide the leadership Bioenergyneeds to take advantage of our strong intellectual property portfolio."
In addition to its pharmaceutical subsidiary company, Bioenergy has twoother subsidiaries. Bioenergy Life Science, Inc. manufactures and sellsD-ribose as an ingredient to nutraceuticals firms marketing beverages andfoods, as a medical food through doctors and clinics and as a dietarysupplement for energy recovery (reduces fatigue, muscle pain, soreness andstiffness following exercise). Viacell, LLC is engaged in developingtechnology related to the enhancement of blood components.
D-Ribose is a naturally occurring monosaccharide the body uses tostimulate the synthesis of adenosine triphosphate (ATP), an essential energycompound. ATP is critical to health and maintaining normal energy-dependentbody functions. Ribose is an essential component in the cellular production ofATP.
D-Ribose has been shown to increase functional capacity for patients withcongestive heart failure (CHF) by improving diastolic heart function,ventilation, exercise capacity, and oxygen uptake efficiency. It's also widelyused to help treat Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS).D-ribose is commonly found in more and more functional foods like energy bars(e.g., Detour, FastFuel, Marathon) and drinks (e.g., Vitamin Water, SoBe LifeWater, Snapple Antioxidant Water).
Bioenergy, Inc. (http://www.bioenergy.com) is a privately held,Minneapolis-based life sciences company whose core technology lies in thedevelopment and commercialization of products based on the physiologicalbenefits of D-ribose in health and wellness.
SOURCE Bioenergy, Inc.